Prometheus Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Prometheus Biosciences

11/08/2021 22:05

* Prometheus Biosciences Inc  RXDX.OQ  reported a quarterly
adjusted loss of 49 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 39 cents per share.
* Revenue was $326.00 thousand​;  analysts expected $150.00
thousand. 
* Prometheus Biosciences Inc's reported EPS for the quarter was
a loss of 49 cents​.
* The mean earnings estimate of analysts had fallen by
about 13.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Prometheus Biosciences Inc shares had fallen by 2.6% this
quarter.
* The company reported a quarterly loss of $19 million.
* Wall Street's median 12-month price target for Prometheus
Biosciences Inc is $34.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 11 at 09:05 p.m.  ​All
figures in US dollars unless otherwise stated